Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up

Conclusions:
Anti-LGI1 encephalitis is a homogenous clinical syndrome, showing early FBDS and other focal seizures with subtle clinical manifestations, followed by memory disturbances. Better recognition will lead to earlier diagnosis, essential for prompt start of treatment. Long-term outcome of surviving patients is mostly favorable, but relapses are common.

Source: Neurology - October 2, 2016 Category: Neurology Authors: van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., Titulaer, M. J. Tags: Autoimmune diseases, Encephalitis, All Epilepsy/Seizures ARTICLE Source Type: research